CINECA IRIS Institutional Research Information System

CERUTI, Maurizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.599
EU - Europa 4.742
AS - Asia 2.523
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 16
SA - Sud America 9
OC - Oceania 7
Totale 13.924
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.563
CN - Cina 1.021
IT - Italia 799
IE - Irlanda 728
DE - Germania 699
SE - Svezia 589
SG - Singapore 470
FI - Finlandia 457
KR - Corea 422
UA - Ucraina 407
JP - Giappone 299
FR - Francia 292
VN - Vietnam 208
GB - Regno Unito 183
PL - Polonia 179
AT - Austria 147
DK - Danimarca 120
IN - India 50
RU - Federazione Russa 43
CA - Canada 33
NL - Olanda 32
BE - Belgio 23
SN - Senegal 23
EU - Europa 13
ID - Indonesia 12
UZ - Uzbekistan 12
IR - Iran 10
GR - Grecia 8
AU - Australia 6
BR - Brasile 6
CZ - Repubblica Ceca 6
HK - Hong Kong 5
ES - Italia 4
HU - Ungheria 4
RO - Romania 4
NO - Norvegia 3
PT - Portogallo 3
A1 - Anonimo 2
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
CH - Svizzera 2
MX - Messico 2
MY - Malesia 2
RS - Serbia 2
TR - Turchia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AR - Argentina 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CO - Colombia 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
IL - Israele 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
LT - Lituania 1
MA - Marocco 1
MD - Moldavia 1
MU - Mauritius 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
SI - Slovenia 1
TH - Thailandia 1
Totale 13.924
Salva come PNG Salva come JPEG
Città #
Chandler 747
Beijing 742
Ann Arbor 730
Dublin 726
Santa Clara 509
Jacksonville 422
Singapore 329
Dearborn 300
Princeton 234
Columbus 200
Houston 183
Boston 181
Ashburn 179
Dong Ket 177
Warsaw 174
Wilmington 171
Villeurbanne 156
Fairfield 151
Vienna 147
Medford 146
Torino 127
Woodbridge 115
Frankfurt am Main 111
Nyköping 95
Munich 81
Fremont 74
Boardman 65
Milan 65
Seattle 64
Cambridge 54
Pisa 45
New York 34
Hefei 32
Falls Church 31
Guangzhou 30
Rome 30
Norwalk 28
Kunming 26
Verona 24
Redwood City 23
Nanjing 21
Brussels 19
Helsinki 19
Washington 17
Düsseldorf 15
Moscow 15
Nanchang 15
Buffalo 14
Cimitile 14
Toronto 13
Hebei 12
San Mateo 12
Hangzhou 11
Jakarta 11
Phoenix 11
Pune 11
Zhengzhou 11
Harbin 9
Chongqing 8
Mumbai 8
Palermo 8
Shanghai 8
Wuhan 8
Bari 7
Fuzhou 7
Gwangjin-gu 7
Lachine 7
San Diego 7
Tulsa 7
Hanover 6
Jinan 6
Los Angeles 6
Paderno Dugnano 6
Shenyang 6
Dallas 5
London 5
Loreto 5
Mountain View 5
Napoli 5
Ottawa 5
Shenzhen 5
Turin 5
Ardabil 4
Aversa 4
Brescia 4
Changsha 4
Hong Kong 4
Lavagna 4
Leawood 4
Matsuyama 4
Monmouth Junction 4
Philadelphia 4
Recife 4
Redmond 4
Ruda Śląska 4
University Park 4
West Jordan 4
Bologna 3
Budapest 3
Castello di Godego 3
Totale 8.229
Salva come PNG Salva come JPEG
Nome #
Carbammati lipidici di farmaci antitumorali. 448
Antifungal activity of bis-azasqualenes, inhibitors of oxidosqualene cyclase 219
Farmaci macromolecolari: veicolazione e direzionamento mediante albumina umana 193
Study of (1-alkoxyethyl)diphenylphosphine oxides. I. Syntheses and structural analyses of phenylethoxy, methoxy and isopentyloxy derivatives. 186
Robinia “Georgia da Torino”. 181
1,5-Benzodiazepines XIV. Synthesis of new substituted 9H-bis[1,2,4]triazolo[4,3-a:3’,4’-d] [1,5]benzodiazepines and relate compounds endowed with in vitro cytotoxic properties 172
Recent studies on the delivery of hydrophilic drugs in nanoparticulate systems. 161
Stereospecific synthesis of squalenoid epoxide vinyl ethers as inhibitors of 2,3-oxidosqualene cyclase. 156
Amphiphilic polyaspartamide copolymer-based micelles for rivastigmine delivery to neuronal cells 156
Analogs of squalene and oxidosqualene inhibit oxidosqualene cyclase of Trypanosoma cruzi expressed in Saccharomyces cerevisiae 154
Stereospecific synthesis of squalenoid epoxide vinyl ethers as inhibitors of 2,3-oxidosqualene cyclase 146
10 and 19-azasqualene derivatives as irreversible inhibitors of 2,3-oxidosqualene cyclase from pig liver. 141
Comparison of experimental and molecular modelling results on phosphine oxides. 140
A Simple Synthesis and some Chemical Properties of Benzo-1,4-dithiafulvenes 135
Study of (1-alkoxyethyl)diphenylphosphine oxides. IV. Conclusive conformational study by NMR and molecular mechanics calculations. 129
Study of (1-alkoxyethyl)diphenylphosphine oxides. II. Conformational analysis by theoretical calculations. 129
Inulin-based polymer coated SPIONs as potential drug delivery systems for targeted cancer therapy 127
Sintesi di inibitori suicidi dello squalene 2,3-epossido ciclasi. 125
Self-assembled squalenoyl-cytarabine nanostructures as a potent nanomedicine for treatment of leukemic diseases 124
Study of (1-alkoxyethyl)diphenylphosphine oxides. III. Nuclear magnetic resonance analysis. 122
[Antiproliferative effect of an extract of Aspergillus terreus] 121
Synthesis of (E)- and (Z)-29-methylidyne-2,3-oxidosqualene derivatives as Inhibitors of Liver and Yeast Oxidosqualene Cyclase. 118
Studio del metabolismo in vivo nel ratto dell'antiparkinson Budipina. 108
Characterization of lipophilic gemcitabine prodrug-liposomal membrane interaction by differential scanning calorimetry 107
Fenil vinil solfuri e metil vinil solfuri, inibitori specifici della ossidosqualene ciclasi di Trypanosoma cruzi e di S. cerevisiae. 105
Structure and reactivity of the dammarenyl cation: configurational transmission in triterpene synthesis 104
Interaction of lipophilic gemcitabine prodrugs with biomembrane models studied by Langmuir-Blodgett technique 102
Sintesi di aldeidi per omologazione di composti carbonilici, via 1,4-benzoditiafulveni. 98
An NMR and molecular mechanics study of squalene and squalene derivatives 96
Vinyl sulfide derivatives of truncated oxidosqualene as selective inhibitors of oxidosqualene and squalene-hopene cyclases 95
Synthesis and biological activity of 22,23-epoxy-2-aza-2,3-dihydrosqualene derivatives: potent new inhibitors of squalene 2,3-oxide - lanosterol cyclase. 95
Synthesis of a squalenoid oxaziridine and other new classes of squalene derivatives, as inhibitors of sterol biosynthesis. 91
2,3-oxidosqualene cyclase and squalene epoxidase, as target enzymes for the development of new sterol biosynthesis inhibitors 91
A new "solid phase" procedure to synthesize immunotoxins (antibody-ribosome inactivating protein conjugates). 91
29-methylidene-2,3-oxidosqualene derivatives as stereospecific mechanism-based inhibitors of liver and yeast oxidosqualene cyclase. 90
Interaction of acyclovir and its squalenoyl-acyclovir prodrug with DMPC in monolayers at the air/water interface 89
19-azasqualene-2,3-epoxide and its N-oxide: metabolic fate and inhibitory effect on sterol biosynthesis in Saccharomyces cerevisiae 87
2,3-oxidosqualene cyclase and squalene epoxidase: enzymology, mechanism and inhibitors 87
Azasqualeni N-ossidi e bis-azasqualeni, inibitori dell'enzima squalene epossido ciclasi. 87
New DSPE-PEG-Folate conjugates for liposomal drug targeting 86
N-oxide as a potential function in the design of enzyme inhibitors. Application to 2,3-epoxysqualene-sterol cyclases. 86
The metabolic fate of the anti-parkinsonian drug budipine in rats. 85
Characterization and partial purification of squalene-2,3-oxide cyclase from Saccharomyces cerevisiae. 84
2-Aza-2,3-dihydrosqualene: biodistribution and pharmacokinetic properties in mice. 84
2,3-oxidosqualene cyclase and squalene epoxidase, as target enzymes for the development of new sterol biosynthesis inhibitors. 83
2,3-oxidosqualene cyclase: from azasqualenes to new site-directed inhibitors. 83
Vinyl sulfide derivatives of oxidosqualene, as inhibitors of oxidosqualene cyclase of Trypanosoma cruzi expressed in Saccharomyces cerevisiae. 82
2,3,4,5-Tetrahydroxy-5-(4-hydroxyphenyl)valeric acid: a new cleavable monofunctional reagent for monoclonal antibody labeling. 82
Synthesis of squalenoid acetylenes and allenes, as inhibitors of squalene epoxidase. 82
Bis(2-Acyloxy or Aroylxybenzenethiolates)Mercury (II) as Inhibitors of “Fusarium” 81
The in vitro metabolism of 1,3-thiazolidine derivatives of theophylline: a study on structure-metabolism correlation. 81
The squalene-2,3-epoxide cyclase as a model for the development of new drugs. 80
A convenient synthesis of [3-3H]squalene and [3-3H]-2,3-oxidosqualene. 80
Antifungal and cytotoxic activity of two inhibitors of 2,3-oxidosqualene cyclase. 79
Synthesis of HEI analogues of the C-20 carbocation forming during lanosterol biosynthesis, as hypocholesterolemics. 79
Total synthesis of the hypocholesterolemic and antifungal drug 10-azasqualene 2,3-epoxide, the first non-cyclized analogue of the C-8 carbonium ion formed during squalene epoxide cyclization. 79
2,3-Oxidosqualene cyclase and squalene epoxidase as target enzymes for the development of new sterol biosynthesis inhibitors 79
Synthesis, characterization and biological activity of new cationic lipids active for gene transfection. 78
2,3-Oxidosqualene cyclase: from azasqualenes to new site-directed inhibitors. 78
A new approach in the synthesis of immunotoxins: ribosome inactivating protein noncovalently bound to monoclonal antibody. 78
Synthesis of new gemcitabine prodrugs for liposome and nanoparticle encapsulation 78
2,3-Epoxy-10-aza-10,11-dihydrosqualene, a high-energy intermediate analogue inhibitor of 2,3-oxidosqualene cyclase. 77
22,23-Epoxy-2-aza-2,3-dihydrosqualene derivatives: potent new inhibitors of squalene 2,3-oxide-lanosterol cyclase. 76
Azasqualene alcohol and derivatives. New selective inhibitors of 2,3-oxidosqualene cyclase. 76
Antifungal and cytotoxic activity of two inhibitors of 2,3-oxidosqualene cyclase 75
Inhibition of 2,3-oxidosqualene cyclase and sterol biosynthesis by 10- and 19-azasqualene derivatives. 74
2,3-oxidosqualene cyclase from yeast: a target enzyme for drug discovery. 74
Synthesis of [3-3H]squalene and [3-3H]-2,3-oxidosqualene. 74
Synthesis of tritium-labelled 19-azasqualene 2,3-epoxide and derivatives, as probes to study their hypocholesterolemic activity. 74
Synthesis and biological activity of aryldithio and maleimido squalene derivatives as new irreversible inhibitors of squalene 2,3-oxide-lanosterol cyclase. 74
In vitro metabolism of 1,3-dioxane, 1,3-oxathiolane and 1,3-dithiane derivatives of theophylline: a structure-metabolism correlation study. 73
2,3,4,5-tetrahydroxy-5-(4-hydroxyphenyl)valeric acid: a new cleavable monofunctional reagent for monoclonal antibody labeling. 72
Synthesis and biological activity of azasqualenes, bis-azasqualenes and derivatives. 72
Antifungal and cytotoxic activiti of two inhibitors of 2,3-oxidosqualene cyclase 72
(E) and (Z)-29-methylidene-2,3-oxidosqualene as stereospecific mechanism-based inhibitors of 2,3-oxidosqualene cyclase. 70
Synthesis, characterization and transfection activity of new saturated and unsaturated cationic lipids 69
Metabolism of 7-(1,3-thiazolidin-2-ylmethyl)theophylline by rat liver microsomes. Evidence for a monooxygenase-dependent step in 1,3-thiazolidine ring cleavage. 69
Studio comparato dell'attività inibitoria di derivati squalenoidi acetilenici ed allenici, nei confronti dell'enzima squalene epossidasi e delle monoossigenasi P-450 dipendenti. 69
Biocompatible micelles based on amphiphilic polyaspartamide-squalene derivatives as potential colloidal drug carriers. 68
Comparison of the mechanism of yeast oxidosqualene cyclase and bacterial squalene cyclase by using rationally designed inhibitors. 68
Studio del metabolismo del 7-(1,3-ditiolan-2-ilmetil)teofillina, un nuovo farmaco ad attività antibroncospastica e mucolitica. 68
Metabolismo ossidativo di funzioni acetaliche e tioacetaliche cicliche: studio della correlazione struttura metabolismo. 68
Inhibition of sterol biosynthesis in Saccharomyces cerevisiae and Candida albicans by 22,23-epoxy-2-aza-2,3-dihydrosqualene and the corresponding N-oxide. 68
An NMR and molecular mechanics study of squalene and squalene derivatives. 66
1H-NMR and 13C-NMR studies for the assignment of the structure of (6E)-10-azasqualene 2,3-epoxide and (6Z)-10-azasqualene 2,3-epoxide and their correlation with hypocholesterolemic and antifungal activity. 65
Total synthesis and inhibition of sterol biosynthesis by 10-azasqualene 2,3-epoxide, a high-energy intermediate analogue 65
Drug design based on biosynthetic studies: synthesis, biological activity, and kinetics of new inhibitors of 2,3-oxidosqualene cyclase and squalene epoxidase. 65
Rational inhibition of sterol biosynthesis: new time-dependent inhibitors of 2,3-oxidosqualene cyclase. 65
Incorporation of lipophilic gemcitabine prodrugs in liposomes 65
Sostanze mutagene e cancerogene in funghi del genere Agaricus. 64
Melphalan monitoring during hyperthermic perfusion of isolated limb for melanoma: pharmacokinetic study and 99mTc-albumin microcolloid technique 63
Preparation, characterization, cytotoxicity and pharmacokinetcs of liposomes containing lipophilic gemcitabine prodrugs 63
Cyanoacrylate nanospheres and nanocapsules containing lipophilic prodrugs of gemcitabine 63
Caratterizzazione e studio dell’attività di una nuova classe di lipidi cationici. 63
Synthesis and inhibition of cholesterol biosynthesis by azasqualene alcohol and derivatives. 63
Synthesis and antibronchospastic activity of theophylline thioacetal derivatives. 63
In vitro metabolism of 7-(1,3-thiazolidin-2ylmethyl)theophylline: the metabolic fate of the 1,3-thiazolidine ring. 63
Stereospecific inhibition of sterol biosynthesis in HEP G2 and Saccharomyces cerevisiae cell cultures by 29-methylidene-oxidosqualene derivatives. 63
2-Aza-2,3-dihydrosqualene and its N-oxide as inhibitors of sterol biosynthesis in bramble cell suspension cultures. 62
Metabolism of 1,1-dichloro-cis-diphenylcyclopropane by rat liver microsomes. 62
Totale 9.656
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.488
article - articoli 0
book - libri 0
conference - conferenze 16.167
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.655
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.377 0 0 0 0 0 345 275 89 266 172 143 87
2020/20211.410 182 49 86 70 127 73 117 37 140 96 126 307
2021/20221.901 71 56 66 139 114 65 144 138 60 140 391 517
2022/20232.335 295 133 37 235 212 697 245 122 212 17 97 33
2023/2024893 140 182 54 30 51 92 19 36 3 44 63 179
2024/20251.403 28 107 58 294 834 82 0 0 0 0 0 0
Totale 14.537